Randomized Controlled Trial

. 2021 Jul 13:374:n1585.

doi: 10.1136/bmj.n1585.

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Manuel R Blum^{1

2}, Bastiaan T G M Sallevelt³, Anne Spinewine^{4

5}, Denis O'Mahony⁶, Elisavet Moutzouri^{1

2}, Martin Feller^{1

2}, Christine Baumgartner¹, Marie Roumet⁷, Katharina Tabea Jungo², Nathalie Schwab^{1

2}, Lisa Bretagne¹, Shanthi Beglinger^{1

2}, Carole E Aubert^{1

2

8

9}, Ingeborg Wilting³, Stefanie Thevelin⁴, Kevin Murphy¹⁰, Corlina J A Huibers¹¹, A Clara Drenth-van Maanen¹¹, Benoit Boland^{12

13}, Erin Crowley¹⁰, Anne Eichenberger¹⁴, Michiel Meulendijk¹⁵, Emma Jennings⁶, Luise Adam^{1

16}, Marvin J Roos¹¹, Laura Gleeson¹⁰, Zhengru Shen¹⁵, Sophie Marien^{12

13}, Arend-Jan Meinders¹⁷, Oliver Baretella^{1

2}, Seraina Netzer^{1

2}, Maria de Montmollin^{1

2}, Anne Fournier⁴, Ariane Mouzon⁵, Cian O'Mahony¹⁰, Drahomir Aujesky¹, Dimitris Mavridis¹⁸, Stephen Byrne¹⁰, Paul A F Jansen³, Matthias Schwenkglenks¹⁹, Marco Spruit^{15

20}, Olivia Dalleur^{4

21}, Wilma Knol¹¹, Sven Trelle⁷, Nicolas Rodondi^{22

2}

Affiliations

¹ Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
³ Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
⁴ Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Belgium.
⁵ Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
⁶ School of Medicine, University College Cork, Cork, Republic of Ireland.
⁷ CTU Bern, University of Bern, Bern, Switzerland.
⁸ Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
⁹ Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
¹⁰ Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Republic of Ireland.
¹¹ Department of Geriatric Medicine and Expertise Centre Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
¹² Geriatric Medicine Division, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
¹³ Institute of Health and Society, Université Catholique de Louvain, Belgium.
¹⁴ Institute of Hospital Pharmacy, Bern University Hospital, University of Bern, Bern, Switzerland.
¹⁵ Department of Information and Computing Sciences, Utrecht University, Utrecht, Netherlands.
¹⁶ Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
¹⁷ Department of Internal Medicine and Intensive Care Unit, St Antonius Hospital, Nieuwegein and Utrecht, Netherlands.
¹⁸ Department of Primary School Education, University of Ioannina, Greece.
¹⁹ Institute of Pharmaceutical Medicine, University of Basel, Basel, Switzerland.
²⁰ Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
²¹ Pharmacy, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
²² Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland nicolas.rodondi@insel.ch.

PMID: 34257088
PMCID: PMC8276068
DOI: 10.1136/bmj.n1585

Randomized Controlled Trial

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Manuel R Blum et al. BMJ. 2021.

. 2021 Jul 13:374:n1585.

doi: 10.1136/bmj.n1585.

Authors

Affiliations

¹ Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
³ Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
⁴ Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Belgium.
⁵ Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
⁶ School of Medicine, University College Cork, Cork, Republic of Ireland.
⁷ CTU Bern, University of Bern, Bern, Switzerland.
⁸ Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
⁹ Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
¹⁰ Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Republic of Ireland.
¹¹ Department of Geriatric Medicine and Expertise Centre Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
¹² Geriatric Medicine Division, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
¹³ Institute of Health and Society, Université Catholique de Louvain, Belgium.
¹⁴ Institute of Hospital Pharmacy, Bern University Hospital, University of Bern, Bern, Switzerland.
¹⁵ Department of Information and Computing Sciences, Utrecht University, Utrecht, Netherlands.
¹⁶ Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
¹⁷ Department of Internal Medicine and Intensive Care Unit, St Antonius Hospital, Nieuwegein and Utrecht, Netherlands.
¹⁸ Department of Primary School Education, University of Ioannina, Greece.
¹⁹ Institute of Pharmaceutical Medicine, University of Basel, Basel, Switzerland.
²⁰ Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
²¹ Pharmacy, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
²² Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland nicolas.rodondi@insel.ch.

PMID: 34257088
PMCID: PMC8276068
DOI: 10.1136/bmj.n1585

Erratum in

Correction for vol. 379, p.
[No authors listed] [No authors listed] BMJ. 2022 Dec 1;379:o2859. doi: 10.1136/bmj.o2859. BMJ. 2022. PMID: 36455932 Free PMC article.

Abstract

Objective: To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital.

Design: Cluster randomised controlled trial.

Setting: 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors.

Participants: 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term).

Intervention: Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person's prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing.

Main outcome measure: Primary outcome was first drug related hospital admission within 12 months.

Results: 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug related hospital admission was 0.91 (0.69 to 1.19). The hazard ratio for first fall was 0.96 (0.79 to 1.15; 237 v 263 first falls) and for death was 0.90 (0.71 to 1.13; 172 v 203 deaths).

Conclusions: Inappropriate prescribing was common in older adults with multimorbidity and polypharmacy admitted to hospital and was reduced through an intervention to optimise pharmacotherapy, but without effect on drug related hospital admissions. Additional efforts are needed to identify pharmacotherapy optimisation interventions that reduce inappropriate prescribing and improve patient outcomes.

Trial registration: ClinicalTrials.gov NCT02986425.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: financial support from grants from Swiss State Secretariat for Education, Research, and Innovation (NR, MSch), EU Horizon 2020 (LG), Gottfried and Julia Bangerter Rhyner Stiftung (LA), European Commission (ST, MR), during the conduct of the study. ST and MR are affiliated with CTU Bern, University of Bern, which has a staff policy of not accepting honorariums or consultancy fees. However, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by not-for-profit and for profit organisations. In particular, pharmaceutical and medical device companies provide direct funding to some of these studies or an up-to-date list of CTU Bern’s conflicts of interest see https://www.ctu.unibe.ch/research/declaration_of_interest/index_eng.html. DOM has a patent A Prescription Decision Support System (based on screening tool of older person’s prescriptions and screening tool to alert to the right treatment (STOPP/START) prescribing rules) issued to European Patent Office (Munich). MS reports a 2011 grant and personal fees from Spru IT, before the conduct of the study; in addition, MS reports a settlement agreement between Spru IT and Utrecht University, in which all systematic tool to reduce inappropriate prescribing (STRIP) assistant IP is transferred to Utrecht University, in exchange for obtaining a free but non-exclusive right to provide STRIP assistant consultancy or support services, or both on a commercial basis, and to update the STRIP assistant, until June 2023.

Figures

**Fig 1**
Flow of participants through study. *Reasons for not receiving intervention in intervention group: discharge or transfer from hospital before intervention could be applied (n=25), patient died before intervention could be applied (n=7), withdrawal from study before intervention could be applied (n=6), and other or unknown (n=9). †Time windows for follow-up interviews: ±14 days at two months; ±30 days at six months; ±30 days at 12 months. ‡Participants or their proxies could not be reached for interview but excludes reasons for study discontinuation. §Reasons listed for exclusion in the per protocol analysis are not mutually exclusive

See this image and copyright information in PMC

References

1. Fortin M, Hudon C, Haggerty J, Akker Mv, Almirall J. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res 2010;10:111. 10.1186/1472-6963-10-111 - DOI - PMC - PubMed
1. Aubert CE, Streit S, Da Costa BR, et al. . Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med 2016;35:35-42. 10.1016/j.ejim.2016.05.022 - DOI - PubMed
1. Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJ, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001;54:680-6. 10.1016/S0895-4356(00)00368-1 - DOI - PubMed
1. Cassell A, Edwards D, Harshfield A, et al. . The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 2018;68:e245-51. 10.3399/bjgp18X695465 - DOI - PMC - PubMed
1. Gnjidic D, Hilmer SN, Blyth FM, et al. . Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012;65:989-95. 10.1016/j.jclinepi.2012.02.018 - DOI - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Affiliations

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Authors

Affiliations

Erratum in

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical